High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey

High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey

Abstract Background Patients with schizophrenia have an increased prevalence of metabolic disturbances compared with the general population. However, the mechanisms underlying the metabolic side effects of antipsychotics are unknown. The aim of the present study was to compare the levels of high-den...

Full description

Bibliographic Details
Main Authors: Shin Ono, Takuro Sugai, Yutaro Suzuki, Manabu Yamazaki, Kazutaka Shimoda, Takao Mori, Yuji Ozeki, Hiroshi Matsuda, Norio Sugawara, Norio Yasui-Furukori, Kurefu Okamoto, Toyoaki Sagae, Toshiyuki Someya
Format: Article
Language:English
Published: BMC 2018-06-01
Series:BMC Psychiatry
Subjects:
Schizophrenia
Antipsychotics
High-density lipoprotein-cholesterol
Metabolic syndrome
Online Access:http://link.springer.com/article/10.1186/s12888-018-1764-1

Internet

http://link.springer.com/article/10.1186/s12888-018-1764-1

Similar Items